Understanding the New Frontiers Study on Cancer Screening in the UAE
A groundbreaking study published in Frontiers in Public Health has shed light on public knowledge, attitudes, and barriers to cancer screening among adults in the United Arab Emirates. Accepted on March 16, 2026, the research titled "Public knowledge, attitudes, and barriers to cancer screening in the UAE: A comprehensive assessment to inform screening practices" provides critical insights into why screening uptake remains low despite national programs. Led by researchers including Anan S. Jarab and Walid Al-Qerem from Al Ain University in Abu Dhabi, the study calls for targeted education campaigns to boost participation.
The research is particularly timely as the UAE grapples with rising cancer incidence. Breast cancer is the leading malignancy among women, accounting for about 37% of female cases, while colorectal cancer is increasingly common in both genders. Despite advanced healthcare infrastructure, screening rates for breast, cervical, colorectal, and prostate cancers lag behind global benchmarks, with estimates suggesting only 20-30% uptake in some categories.
The Growing Cancer Burden in the UAE
Cancer represents a significant public health challenge in the UAE, with the National Cancer Registry reporting over 7,500 new cases in 2023 alone. Age-standardized incidence rates stand at approximately 107 per 100,000 population, with breast cancer topping the list for women (ASR 36.9 per 100,000) and prostate and colorectal cancers prominent among men. Projections indicate a continued rise due to lifestyle factors like obesity, smoking, and delayed diagnoses.
The UAE has implemented national screening protocols for breast (mammography for women over 40), cervical (Pap smears for 21-65), colorectal (FIT for 50+), and emerging prostate programs. However, uptake is low—unofficial reports estimate breast screening at around 23.5% among eligible Abu Dhabi nationals in 2015-2016, with similar trends persisting. Recent 2026 announcements signal plans for mandatory nationwide screening, including lung cancer, to address this gap.
Methodology of the Comprehensive UAE Study
The cross-sectional study surveyed a representative sample of UAE adults, employing a structured questionnaire to gauge knowledge of screening guidelines, attitudes toward tests, practices, and perceived barriers. Conducted amid the country's diverse population (Emiratis and expatriates), it focused on common cancers: breast, cervical, colorectal, and prostate.
Researchers from Al Ain University and collaborators used validated scales, ensuring cultural sensitivity. Statistical analysis included chi-square tests and logistic regression to identify demographic predictors like age, gender, education, and nationality. This rigorous approach provides robust data for policymakers.
Knowledge Gaps in Cancer Screening Guidelines
The study revealed moderate to low knowledge levels. Only a fraction of respondents correctly identified screening ages and frequencies. For breast cancer, awareness of annual mammograms post-40 was around 50%, lower for cervical (Pap every 3 years) and colorectal (FIT biennially). Prostate screening (PSA from 50) was least known, especially among women.
- Less than 40% knew breast screening starts at 40 for average risk.
- Colorectal knowledge hovered at 35%, with confusion over FIT vs. colonoscopy.
- Higher education correlated with better knowledge (OR 2.5).
These gaps underscore the need for university-led public health campaigns.
Attitudes Toward Cancer Screening: Fear and Stigma Persist
Attitudes were mixed, with favorable views on screening's benefits but unfavorable perceptions due to fear of pain, radiation, and false positives. Over 60% believed screening saves lives, yet 45% viewed it as unnecessary if asymptomatic. Cultural stigma around prostate and cervical exams was notable, particularly among conservative groups.
Positive attitudes were higher among screened individuals (75% vs. 40%). The study highlights how misconceptions amplify reluctance, aligning with prior UAEU research on colorectal screening.
Photo by Vito Natale on Unsplash
Key Barriers Identified in the UAE Context
Barriers ranked highly: lack of awareness (top for all), access issues, cost perceptions (despite free programs for nationals), time constraints, and embarrassment. For colorectal, invasiveness deterred 55%; for breast, fear topped at 50%.
| Cancer Type | Top Barriers (%) |
|---|---|
| Breast | Lack of awareness (62%), Fear (48%) |
| Cervical | Embarrassment (52%), Access (40%) |
| Colorectal | Invasiveness (55%), Awareness (60%) |
| Prostate | Stigma (58%), Knowledge gap (65%) |
Read the full Frontiers study for detailed rankings.
Demographic Differences and Vulnerable Groups
Younger adults (<40) and expatriates showed lower knowledge; women outperformed men on breast/cervical but lagged on prostate. Low education and rural residence amplified barriers. Emiratis had better access but similar attitudes, suggesting education's universal need.
UAE Universities Leading Cancer Research Efforts
Al Ain University spearheaded this study, joining UAEU's colorectal research and Abu Dhabi University's new Cancer Research Institute (launched Jan 2026). University of Sharjah's Center of Excellence and Khalifa University's modeling initiatives drive innovation. These institutions collaborate on translational research, training future oncologists via programs like research jobs.
ADU Cancer Research Institute exemplifies higher ed's role.
National Screening Programs and Recent Advances
UAE's programs, free for nationals, cover key cancers via HAAD/DOH. 2026 updates include mandatory multi-cancer blood tests in Abu Dhabi. Uptake challenges persist, but digital reminders and mobile units show promise.
Recommendations: Education and Policy Shifts
The study urges tailored campaigns via social media, mosques, workplaces; physician endorsements; and community outreach. Universities can lead via public lectures, apps. Integrate screening into annual checkups.
- Target low-awareness groups with multilingual materials.
- Address stigma through role models.
- Monitor via registries for impact.
Future Outlook for UAE Cancer Prevention
With Vision 2031 emphasizing health, university research positions UAE as regional leader. Collaborations with global partners and AI for risk prediction promise higher uptake. Early detection could cut mortality 30%.
Explore careers advancing this at UAE academic jobs.
